Maria Oliva-Hemker
#120,100
Most Influential Person Now
American paediatrician
Maria Oliva-Hemker's AcademicInfluence.com Rankings
Maria Oliva-Hemkerphilosophy Degrees
Philosophy
#11561
World Rank
#15940
Historical Rank
Logic
#8911
World Rank
#11218
Historical Rank
Download Badge
Philosophy
Maria Oliva-Hemker's Degrees
- Doctorate Medicine University of California, San Francisco
Why Is Maria Oliva-Hemker Influential?
(Suggest an Edit or Addition)According to Wikipedia, Maria M. Oliva-Hemker is a Cuban-American pediatrician. She is the Stermer Family Professor of Pediatric Inflammatory Bowel Disease , Director of the Division of Pediatric Gastroenterology, Hepatology and Nutrition and Vice Dean for Faculty at the Johns Hopkins University School of Medicine.
Maria Oliva-Hemker's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study (2017) (390)
- A Randomized, Double‐blind Trial of Lactobacillus GG Versus Placebo in Addition to Standard Maintenance Therapy for Children with Crohn's Disease (2005) (363)
- Evaluation of the Pediatric Crohn Disease Activity Index: A Prospective Multicenter Experience (2005) (299)
- Inflammatory Bowel Disease Characteristics Among African Americans, Hispanics, and Non-Hispanic Whites: Characterization of a Large North American Cohort (2006) (264)
- Appraisal of the pediatric ulcerative colitis activity index (PUCAI) (2009) (241)
- Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease. (2014) (212)
- Long‐term outcome of maintenance infliximab therapy in children with Crohn's disease (2009) (187)
- TGFβ Receptor Mutations Impose a Strong Predisposition for Human Allergic Disease (2013) (167)
- Growth Abnormalities Persist in Newly Diagnosed Children With Crohn Disease Despite Current Treatment Paradigms (2009) (142)
- The natural history of corticosteroid therapy for ulcerative colitis in children. (2006) (140)
- Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease and Their Relation to Disease Type and Severity (2010) (137)
- Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course. (2018) (130)
- Challenges in pediatric inflammatory bowel disease. (2006) (129)
- Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in Pediatric Crohn’s Disease (2009) (129)
- Laboratory Values for Children With Newly Diagnosed Inflammatory Bowel Disease (2007) (127)
- Effect of early immunomodulator use in moderate to severe pediatric Crohn disease (2008) (126)
- Indeterminate colitis: A significant subgroup of pediatric IBD (2006) (122)
- Outcome Following Infliximab Therapy in Children With Ulcerative Colitis (2010) (122)
- Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. (2006) (114)
- Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. (2007) (103)
- Outcome After Percutaneous Endoscopic Gastrostomy in Children and Young Adults (2010) (102)
- Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial (2003) (100)
- Gadolinium-enhanced Magnetic Resonance Imaging: A Useful Radiological Tool in Diagnosing Pediatric IBD (2004) (100)
- Health‐related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease (2006) (98)
- Course and Treatment of Perianal Disease in Children Newly Diagnosed with Crohn's Disease (2009) (96)
- Age of diagnosis influences serologic responses in children with Crohn's disease: A possible clue to etiology? (2008) (92)
- Infliximab Efficacy in Pediatric Ulcerative Colitis (2005) (87)
- Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort. (2015) (85)
- Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study (2019) (84)
- Etiopathogenesis of Inflammatory Bowel Disease: The Importance of the Pediatric Perspective (2002) (80)
- Factors that determine risk for surgery in pediatric patients with Crohn's disease. (2010) (80)
- Magnet Ingestions in Children Presenting to US Emergency Departments, 2002–2011 (2013) (77)
- Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease. (2015) (76)
- Real‐time tool to display the predicted disease course and treatment response for children with Crohn's disease (2011) (73)
- Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease (2015) (72)
- The Prevalence of Clostridium difficile Infection in Pediatric and Adult Patients with Inflammatory Bowel Disease (2014) (62)
- Nonadherence With Thiopurine Immunomodulator and Mesalamine Medications in Children with Crohn Disease (2007) (61)
- Outcome Following Thiopurine Use in Children With Ulcerative Colitis: A Prospective Multicenter Registry Study (2011) (61)
- Clostridium difficile Carriage and Serum Antitoxin Responses in Children with Inflammatory Bowel Disease (2013) (59)
- Percutaneous endoscopic gastrostomy in small medically complex infants. (2001) (59)
- Probiotics in Primary Care Pediatrics (2006) (54)
- MR enterography findings of inflammatory bowel disease in pediatric patients. (2011) (52)
- Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children. (2020) (52)
- Outcome Following Aminosalicylate Therapy in Children Newly Diagnosed As Having Ulcerative Colitis (2013) (46)
- Gastrointestinal Symptoms Associated with Orthostatic Intolerance (2005) (44)
- Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease. (2018) (44)
- Fecal microbiota transplantation in children: a brief review (2016) (41)
- Disease Presentation and Clinical Course in Black and White Children With Inflammatory Bowel Disease (2007) (40)
- Infliximab use and hepatosplenic T cell lymphoma: questions to be asked and lessons learned. (2007) (39)
- Nutritional outcomes following gastrostomy in children with cystic fibrosis (2012) (38)
- Factors associated with early outcomes following standardized therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study (2017) (38)
- Biologics Delay Progression of Crohn’s Disease, but Not Early Surgery, in Children (2018) (36)
- NOD2 Mutations and Anti-Saccharomyces cerevisiae Antibodies Are Risk Factors for Crohn's Disease in African Americans (2010) (34)
- Contribution of higher risk genes and European admixture to Crohn's disease in African Americans (2012) (32)
- Retrospective Cohort Study of Methotrexate Use in the Treatment of Pediatric Crohn's Disease (2014) (32)
- Recognizing Gastrointestinal and Hepatic Manifestations of Primary Immunodeficiency Diseases (2010) (30)
- Malnutrition increases the risk of 30-day complications after surgery in pediatric patients with Crohn disease. (2017) (30)
- Fecal Transplant in Children With Clostridioides difficile Gives Sustained Reduction in Antimicrobial Resistance and Potential Pathogen Burden (2019) (29)
- Efficacy and Tolerance of Blended Diets in Children Receiving Gastrostomy Feeds. (2020) (29)
- Nutritional considerations in pediatric inflammatory bowel disease (2010) (27)
- Pediatric ulcerative colitis: current treatment approaches including role of infliximab (2012) (25)
- Pernicious anemia and widespread absence of gastrointestinal endocrine cells in a patient with autoimmune polyglandular syndrome type I and malabsorption. (2006) (25)
- Medical malpractice in gastroenterology. (2008) (23)
- The Effect of Early‐Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children (2018) (23)
- Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide. (2003) (23)
- Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile. (2019) (22)
- Pediatric Jejunoileitis:: A Severe Crohn's Disease Phenotype That Requires Intensive Nutritional Management (2004) (20)
- Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease (2015) (20)
- Liver Enzyme Elevations Within 3 Months of Diagnosis of Inflammatory Bowel Disease and Likelihood of Liver Disease (2014) (17)
- Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study. (2019) (17)
- Age-of-Diagnosis Dependent Ileal Immune Intensification and Reduced Alpha-Defensin in Older versus Younger Pediatric Crohn Disease Patients despite Already Established Dysbiosis (2018) (16)
- Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis. (2018) (16)
- Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study (2017) (14)
- Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children. (2018) (14)
- Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease (2010) (13)
- Life-Threatenting Ceftriaxone-Induced Immune Hemolytic Anemia in a Child with Crohn’s Disease (2004) (13)
- Mucosal Inflammatory and Wound Healing Gene Programs Reveal Targets for Stricturing Behavior in Pediatric Crohn's Disease. (2020) (11)
- Decreased Fecal Bacterial Diversity and Altered Microbiome in Children Colonized With Clostridium difficile (2019) (10)
- IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel disease (2021) (9)
- Refractory Inflammatory Bowel Disease in Children (2008) (9)
- Malignant peritoneal mesothelioma in a pediatric patient mimicking inflammatory bowel disease. (2004) (9)
- CASE REPORT: Malignant Peritoneal Mesothelioma in a Pediatric Patient Mimicking Inflammatory Bowel Disease (2004) (7)
- Lymphocytic and Collagenous Colitis in Children and Adolescents: Comprehensive Clinicopathologic Analysis with Long-Term Follow Up. (2020) (7)
- Celiac Disease. (2018) (6)
- Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease. (2021) (5)
- Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease (2013) (5)
- W1219 Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (Reseat) in Pediatric Crohn's Disease (2008) (4)
- Outcomes of Combined Medical and Behavioral Treatments for Constipation Within a Specialty Outpatient Clinic (2017) (4)
- Outcomes Following Aminosalicylate Therapy in Children Newly Diagnosed With Ulcerative Colitis: A Prospective Multi-Center Registry Experience (2011) (4)
- Budesonide Use in Pediatric Crohn Disease (2012) (4)
- Evaluation of a free amino acid–based formula in infants with presumptive food protein–induced proctocolitis (2014) (4)
- S1189 Upper Gastrointestinal Involvement in Pediatric Crohn's Disease: Experience of a Large Multicenter Inception Cohort (2010) (4)
- Two single group, prospective, baseline-controlled feeding studies in infants and children with chronic diarrhea fed a hypoallergenic free amino acid-based formula (2014) (4)
- The Prometheus Crohn's Prognostic Test Does Not Reliably Predict Complicated Crohn's Disease in Children (2011) (3)
- Infliximab for the treatment of pediatric ulcerative colitis (2012) (3)
- P0712 RE-EVALUATION OF THE PEDIATRIC CROHN???S DISEASE ACTIVITY INDEX: USEFULNESS IN THE PRACTICE SETTING (2004) (2)
- 1108 A Prediction Tool to Help Children with Crohn's Disease and Their Parents Understand Individualized Risks of Disease Complications and Response to Therapy (2009) (2)
- MACHINE LEARNING FOR CROHN’S DISEASE PHENOTYPE MODELING USING BIOPSY IMAGES (2021) (2)
- 500 Inherent Differences in 6mp Transport in Human Lymphocytes: Correlation with Drug-Induced Cytotoxicity (2008) (2)
- INFLAMMATORY BOWEL DISEASE (IBD) IN AFRICAN AMERICAN CHILDREN: 151 (2005) (2)
- 168 Microbiome Changes Associated With Sustained Eradication of Clostridium difficile After Fecal Microbiota Transplantation in Children With and Without Inflammatory Bowel Disease (2015) (1)
- Clinical Effectiveness and Safety of Fecal Microbiota Transplantation in Children for Clostridium Difficile infection: Results from 9 Pediatric Centers in the United States: 2016 ACG Presidential Poster Award: 1038 (2016) (1)
- 692 Impact of Body Mass Index on Efficacy of Infliximab in Children With Inflammatory Bowel Disease (2013) (1)
- 139 Long-Term Outcomes After Institution of Adalimumab Therapy in Pediatric Crohn Disease (2012) (1)
- Su2017 - Predicting Response to Standardized Pediatric Colitis Therapy: The Protect Study (2018) (1)
- Initial response to treatment (Rx) and need for intensified (step-up) therapy in children with newly diagnosed, inflammatory bowel disease (IBD): A preliminary investigation by the pediatric IBD collaborative research group (2003) (1)
- P0692 MEDICATION ADHERENCE IN PEDIATRIC CROHN???S DISEASE (2004) (1)
- 953 Prolonged Exposure to Prednisone Is Decreasing in Children With Inflammatory Bowel Disease (IBD) During the Last Decade (2013) (1)
- Sa1884 Infliximab Versus Immunomodulator as First Maintenance Therapy in Children With Crohn Disease (2012) (1)
- 829 Early Anti-TNFα Therapy Is Superior to Early Immunomodulator Therapy in Newly Diagnosed Children With Crohn's Disease (2013) (1)
- 506 Outcome Following Thiopurine use in Children With Ulcerative Colitis: A Prospective Multicenter Study (2010) (1)
- Early Anti-TNF is Effective in Preventing Internal Penetrating but not Stricturing Disease Complications in Children Newly Diagnosed with Crohn's Disease: A Prospective Risk Prediction Model for Disease Behavior Study (2017) (1)
- P0666 LAB PARAMETERS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE (IBD) AT DIAGNOSIS (2004) (1)
- IMPACT-II QOL questionnaire: Performance in new-onset pediatric IBD patients (the pediatric IBD collaborative registry) (2003) (1)
- 425 – Durable Transfer of Candidate Procarcinogenic Bacteria During Fecal Microbiota Transplantation in a Prospective Cohort Study of Pediatric Patients with Recurrent Clostridioides Difficile (2019) (1)
- W1188 Growth in Pediatric Patients with IBD Treated with Infliximab or 6-Mercaptopurine/Azathioprine (2009) (1)
- Gadolinium enhanced magnetic resonance imaging (G-MRI) in diagnosing pediatric inflammatory bowel disease (2000) (1)
- Bile Acid Composition Changes over 6 Months Following Fecal Microbiota Transplantation in Children with Recurrent C. difficile Infections: 2016 ACG Presidential Poster Award: 1043 (2016) (1)
- Sa2016 - Fecal Microbiota Transplantation for Clostridium Difficile in Patients with Inflammatory Bowel Disease; the Pediatric Perspective (2018) (1)
- PATTERNS OF INFLIXIMAB USE IN CHILDREN WITH CROHN DISEASE (2006) (1)
- O-11: Real world outcomes of contemporary treatments in children with Crohn’s disease: observations from the pediatric IBD collaborative research group registry (2014) (1)
- The role of parent and child catastrophizing in pediatric inflammatory bowel disease pain and functioning (2010) (1)
- 141 Assessment of Durability of Infliximab Maintenance Therapy in Children With Crohn's Disease (2012) (1)
- W1225 Budesonide Is An Effective But Underutilized Therapy in Pediatric Crohn Disease (2008) (0)
- Is Mesalamine Monotherapy Equally Effective in Inducing Remission in Mild Versus Moderate Pediatric Ulcerative Colitis at Diagnosis (2017) (0)
- 634 - Gut Microbial Factors Implicated in Disease Progression and Treatment Response in Pediatric Ulcerative Colitis (2018) (0)
- Changing Trends in Pharmacologic Therapy of Pediatric Crohn's Disease (2011) (0)
- 831 Prospective Cohort Study of Methotrexate Use in Treatment of Pediatric Crohn Disease (2013) (0)
- Prevalence of Enterotoxigenic Bacteroides fragilis Detected in Stool Samples from Pediatric Inflammatory Bowel Disease Patients: 1931 (2012) (0)
- 202 In African Americans, NOD2, SLC22A5 and ATG16L1 But Not Il23R or IRGM Are Genetic Risk Factors for Crohn's Disease (2009) (0)
- CD4+ T-LYMPHOCYTE ATP LEVELS: A SENSITIVE MARKER FOR INFLIXIMAB INDUCED IMUNNOSUPPRESSION IN PEDIATRIC PATIENTS WITH IBD: 175 (2005) (0)
- S2023 NOD2 Mutations and Presenting Clinical Characteristics of Crohn's Disease (CD) in Children (2010) (0)
- Clinical Indications for Use of Probiotics in the Pediatric Population PROBIOTICS: THE HOPE, THE HYPE, AND THE REALITY, SERIES #4 (2005) (0)
- P0130 PP NOD2 POLYMORPHISMS AND THEIR RELATIONSHIP TO SEROLOGIC MARKERS OF DISEASE IN CHILDREN WITH IBD (2004) (0)
- DOES AGE AT ONSET AFFECT IBD TREATMENT? (2006) (0)
- Gadolinium enhanced MRI (G-MRI) is useful in differentiating Crohn's disease (CD) from ulcerative colitis (UC) in children with IBD (2001) (0)
- P-0128: Pain and pain catastrophizing in pediatric Inflammatory Bowel Disease (2009) (0)
- RESOURCE UTILIZATION FOR CHILDREN WITH NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASE: 178 (2005) (0)
- Human-centered design of clinical decision support for anemia screening in children with inflammatory bowel disease. (2023) (0)
- P0589 INDETERMINATE COLITIS: A SIGNIFICANT SUBGROUP OF PEDIATRIC IBD (2004) (0)
- Sa1982 Detecting Enterotoxigenic Bacteroides Fragilis Carriage in Pediatric Inflammatory Bowel Disease (2012) (0)
- NOD2 VARIANTS IN CHILDREN WITH CROHN DISEASE ARE ASSOCIATED WITH ONSET OF DISEASE IN THE FIRST DECADE OF LIFE: 784 (2004) (0)
- Expert Review of Gastroenterology & Hepatology (2012) (0)
- 90 Durability of Maintenance Infliximab Therapy in Children With Crohn's Disease: Are Gender and Concomitant Immunomodulators More Important Than We Thought? (2014) (0)
- Su1829 Mutations in TGFβR1 and 2 Are Associated With Food Allergy, Eosinophilic Gastrointestinal Disease, and Inflammatory Bowel Disease (2013) (0)
- Diagnosis and Management of Microscopic Colitis in Pediatric Patients (2022) (0)
- Changing trends in growth abnormalities in children with IBD: A preliminary investigation by the pediatric IBD collaborative research group (2003) (0)
- S2005 Clinical Effect and Changing Patterns of use of Methotrexate in the Treatment of Pediatric Crohn's Disease: A Multi-Center Experience (2010) (0)
- Sa1999 Patient Related Outcomes and Disease Activity Indices in New Onset Pediatric Ulcerative Colitis: The PROTECT Study (2015) (0)
- Longitudinal bile acid composition changes following fecal microbiota transplantation for Clostridioides difficile infection in children with and without underlying inflammatory bowel disease. (2023) (0)
- Predicting Non-Response to Intravenous Corticosteroid Induction Therapy in Children Newly Diagnosed with Severely Active Ulcerative Colitis: The Protect Study (2017) (0)
- Refractory Inflammatory Bowel Disease in Children (2018) (0)
- 441 Endoscopic Assessment of Mucosal Activity in Pediatric Ulcerative Colitis: Are Current Methods Reliable? (2014) (0)
- 140 Anti-Microbial Serology Patterns in 824 Children With Newly Diagnosed Crohn's Disease: Association With GM-CSF Auto-Antibodies and Specific Clinical Phenotypes (2012) (0)
- PERIANAL FISTULAE IN PEDIATRIC CROHN DISEASE: THERAPIES AND COURSE (2006) (0)
- Percutaneous endoscopic gastrostomy (PEG) placement in medically complex infants weighing less than 3.5 kilograms (1998) (0)
- THE PRECIOUS STUDY: A PROSPECTIVE, OBSERVATIONAL STUDY OF CD8+ BIOMARKER BASED PROGNOSTIC TEST IN NORTH AMERICAN IBD PATIENTS (2023) (0)
- IDENTIFYING RELEVANT PATHWAYS AND BIOMARKERS IN CROHN’S DISEASE USING CONTEXTUALIZED METABOLIC NETWORK MODEL (2021) (0)
- 832 Clostridium difficile Carriage and Serum Antibody Responses in Pediatric Outpatients With Inflammatory Bowel Disease (2013) (0)
- 924 Long-Term Outcome Following Infliximab Therapy in Pediatric Patients with Crohn Disease: Results from a Multicenter Study (2008) (0)
- Usefulness of Single Balloon Enteroscopy in Pediatric Crohn's Disease (2011) (0)
- 27 - Longitudinal Sustained Microbiome Changes with Fecal Microbiota Transplantation in Children with Recurrent Clostridium Difficile Infection Revealed by Shotgun Metagenomic Sequencing (2018) (0)
- Utilizing Information Technology to Improve Influenza Vaccination in Pediatric Patients With Inflammatory Bowel Disease (2019) (0)
- 634 Serologic Reactivity Reflects Clinical and Genetic Expression of Ulcerative Colitis in Children. The Protect Study (2016) (0)
- Su1234 Histologic Correlates of Clinical and Endoscopic Severity in Newly Diagnosed Pediatric Ulcerative Colitis: The PROTECT Study (2015) (0)
- Sa1090 – Anemia in Pediatric Inflammatory Bowel Disease: What Do Providers Want from Electronic Clinical Decision Support? (2019) (0)
- Clostridioides difficile Infection in Hospitalized Pediatric Patients: Comparisons of Epidemiology, Testing, and Treatment from 2013-2019. (2022) (0)
- Su1195 Simple Blood Testing Defines Severe New Onset Ulcerative Colitis in Children: The PROTECT Study (2015) (0)
- Microbial Dysbiosis Associated with Disease Severity in Treatment Naive Pediatric Patients with New-Onset Ulcerative Colitis (2017) (0)
- P0687 CHARACTERIZATION OF HEIGHT AND WEIGHT PATTERNS IN NEWLY DIAGNOSED CHILDREN WITH INFLAMMATORY BOWEL DISEASE (IBD) (2004) (0)
- P0724 INFLIXIMAB EFFICACY IN PEDIATRIC ULCERATIVE COLITIS (2004) (0)
- 740 - Age-of-Onset Dependent Ileal Immune Maturation and Reduced Alpha-Defensin in Pediatric Crohn Disease with Already Established Dysbiosis (2018) (0)
- W1103 Anti-CBIR1 Is Commonly Detectable in Children with Ulcerative Colitis, But Does Not Predict Disease Course Over the First 2 Years of Treatment (2009) (0)
- Su2010 The Prevalence of Clostridium difficile Infection in Hospitalized Pediatric and Adult Patients With Inflammatory Bowel Disease (2013) (0)
- Suboptimal Early Outcomes following Standardized Induction Therapy in Children Newly Diagnosed with Ulcerative Colitis: The Protect Study (2017) (0)
- W1198 Medication Use and Disease Characteristics in Early-Onset and Later-Onset Pediatric Inflammatory Bowel Disease (IBD) (2009) (0)
- 142 Prospective Multicenter Pediatric Cohort Study: Patients With Liver Enzyme Elevations in the First 3 Months After Diagnosis of Inflammatory Bowel Disease are at Increased Risk of Chronic Liver Disease (2012) (0)
- O07 Predictors of Clinical Outcome in Children with Ulcerative Colitis (UC) (2009) (0)
- GENE EXPRESSION PROFILES IN CHILDREN WITH NEWLY DIAGNOSED CROHN'S DISEASE: 203 (2005) (0)
- BODY MASS INDEX (BMI) OF IBD CHILDREN AT DIAGNOSIS; THE EFFECTS OF OBESITY EPIDEMIC: 826 (2004) (0)
- 935 PRE-TREATMENT MUCOSAL INFLAMMATORY AND WOUND HEALING GENE PROGRAMS REVEAL MECHANISMS ASSOCIATED WITH FUTURE STRICTURING BEHAVIOR DURING FIVE YEAR FOLLOW-UP IN PEDIATRIC CROHN'S DISEASE (2020) (0)
- P0615 STEROID THERAPY IN THE AGE OF INFLIXIMAB (IFX): IMMEDIATE AND 1 YEAR OUTCOME IN NEWLY DIAGNOSED CHILDREN WITH CROHN DISEASE (CD) (2004) (0)
- 394 Age of Diagnosis Influences Serologic Responses in Children with Crohn Disease: A Possible Clue to Etiology? (2008) (0)
- Can we Simplify the Pediatric Ulcerative Colitis Index to the Point of Patient-Reported Outcomes Only? (2017) (0)
- 54 High Frequency of Non-Classical Endoscopic Findings in Children and Adolescents Diagnosed With UlcerativE.ColiTis. The Protect Study (2017) (0)
- 45 Decreased Diversity of the Fecal Microbiome in Pediatric Carriage of Clostridium difficile (2014) (0)
- The 2017 Shwachman Award. (2018) (0)
- Tu1190 Clinical Outcome and Prediction of Final Diagnosis in Pediatric Inflammatory Bowel Disease Unclassified (IBD-U) Patients (2014) (0)
- Annual update of pediatric digestive diseases (2011) (0)
- 21 Surgery in Pediatric Crohn's Disease, 2002-2014 (2016) (0)
- 497 - Irrespective of Initial Ulcerative Colitis Therapy Thiopurines Unlikely to Result in Corticosteroid-Free Remission One Year after Diagnosis (2018) (0)
- 2092 A multicenter study of fecal microbiota transplantation for Clostridium difficile infection in children (2018) (0)
- Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Pediatric Patients (2023) (0)
- Improving the status of clinical trials in pediatric gastrointestinal diseases. (2002) (0)
- W1189 Indeterminate Colitis (IC) in Children: A Two-Year Follow-Up (2009) (0)
- A Mendelian Presentation of Multiple TH2-Mediated Allergic Diseases (2013) (0)
- W1196 Utilization and Effect of Methotrexate in the Treatment of Pediatric Crohn's Disease: A Multi-Center Experience (2009) (0)
- Long Term Use of Adalimumab in Pediatric Crohnʼs Disease: A Multi-Center Study: 1458 (2009) (0)
- Post-Intestinal Resection Management of Pediatric Crohn's Disease (2011) (0)
- 834 Ileal Transcriptome Analysis Reveals Mucosal Immune Maturation With Increasing Age-of-Onset in Pediatric Crohn Disease and Healthy Controls - A Mucosal Gene Expression Based Signature That Supports the Paris Classification for Age-of-Onset (2013) (0)
- Predicting Response to Oral Corticosteroid Induction Therapy in Children Newly Diagnosed with Moderately Active Ulcerative Colitis: The Protect Study (2017) (0)
- Greater Contribution of HLA to Risk for Pediatric-Onset Ulcerative Colitis Can be Narrowed to 3 Independent Classic HLA Variants and Corresponding Amino Acid Changes (2017) (0)
- PITYRIASIS ROSEA-LIKE ERUPTION DURING INFLIXIMAB TREATMENT (2006) (0)
- Predicting Response to Mesalamine Induction Therapy in Children Newly Diagnosed with Mild-to-Moderate Ulcerative Colitis: The Protect Study (2017) (0)
- Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis (2018) (0)
- 961 Long-Term Outcome of Children With Crohn's Disease: Results From a Large Multi-Center North American Inception Cohort (2014) (0)
- 1162 BASELINE ILEAL LUMINAL NARROWING IS ASSOCIATED WITH SPECIFIC PRE-TREATMENT MUCOSAL GENE PROGRAMS AND MICROBIAL SHIFTS AND SUBSEQUENT LIKELIHOOD OF TRANSMURAL HEALING IN PEDIATRIC CROHN'S DISEASE (2020) (0)
This paper list is powered by the following services:
Other Resources About Maria Oliva-Hemker
What Schools Are Affiliated With Maria Oliva-Hemker?
Maria Oliva-Hemker is affiliated with the following schools:
